Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Frankfurt - Delayed Quote • EUR Insulet Corporation (GOV.F) Follow Compare 232.70 -15.30 (-6.17%) At close: 9:57:25 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for GOV.F 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: GOV.F View More All News Press Releases SEC Filings Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025 Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks 3 Reasons Investors Love Insulet (PODD) Insulet Gains 62.9% in a Year: What's Driving the Stock? Insulet (NasdaqGS:PODD) Completes US$450 Million Debt Financing; 7 Day Share Price Up 5% PODD Stock Gains Following the Launch of Omnipod 5 in Australia Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5 LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections